CNTA - CIK 0001847903
Centessa Pharmaceuticals plc has filed 579 documents with the SEC between 2021 and 2026. The most frequent type is insider trade (261 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2026-05-22 | 2026-05-21 |
| Insider trade | 4 | 2026-05-18 | 2026-05-01 |
| SCHEDULE 13G | - | 2026-05-15 | - |
| SCHEDULE 13G/A | - | 2026-05-15 | - |
| SCHEDULE 13G/A | - | 2026-05-13 | - |
| DEFM14A | - | 2026-05-07 | - |
| SCHEDULE 13G/A | - | 2026-05-06 | - |
| Quarterly report | 10-Q | 2026-05-05 | 2026-03-31 |
| Annual report to shareholders | ARS | 2026-04-29 | 2025-12-31 |
| Proxy statement | DEF 14A | 2026-04-29 | 2026-06-12 |
| PREM14A | - | 2026-04-17 | 2026-04-17 |
| Proxy materials | DEFA14A | 2026-04-13 | - |
| Employee stock plan | S-8 | 2026-03-31 | - |
| Annual report | 10-K | 2026-03-31 | 2025-12-31 |
| Proxy materials | DEFA14A | 2026-03-31 | - |
| Proxy materials | DEFA14A | 2026-03-31 | - |
| Proxy materials | DEFA14A | 2026-03-31 | - |
| Proxy materials | DEFA14A | 2026-03-31 | - |
| Proxy materials | DEFA14A | 2026-03-31 | - |
| Major company event | 8-K | 2026-03-31 | 2026-03-31 |
| DFAN14A | - | 2026-03-31 | - |
| Insider trade | 4 | 2026-03-27 | 2026-03-26 |
| Insider sale notice | 144 | 2026-03-26 | - |
| Insider sale notice | 144 | 2026-03-26 | - |
| Insider trade | 4 | 2026-03-26 | 2026-03-26 |
| Insider trade | 4 | 2026-03-18 | 2026-03-16 |
| Insider sale notice | 144 | 2026-03-17 | - |
| Insider sale notice | 144 | 2026-03-16 | - |
| Insider trade (amended) | 4/A | 2026-03-16 | 2026-03-13 |
| Insider sale notice | 144 | 2026-03-13 | - |
| Insider sale notice | 144 | 2026-03-13 | - |
| Insider trade | 4 | 2026-03-13 | 2026-03-13 |
| Insider trade | 4 | 2026-03-13 | 2026-03-13 |
| SCHEDULE 13G/A | - | 2026-02-17 | - |
| Major company event | 8-K | 2026-02-13 | 2026-02-09 |
| SCHEDULE 13G/A | - | 2026-02-06 | - |
| SCHEDULE 13G/A | - | 2026-02-05 | - |
| Insider trade | 4 | 2026-02-03 | 2026-02-02 |
| Insider trade | 4 | 2026-02-03 | 2026-02-02 |
| Insider trade | 4 | 2026-02-03 | 2026-02-02 |
| Insider trade | 4 | 2026-02-03 | 2026-01-30 |
| Insider trade | 4 | 2026-02-03 | 2026-02-01 |
| Insider trade | 4 | 2026-02-03 | 2026-02-01 |
| Insider trade | 4 | 2026-02-03 | 2026-02-01 |
| Insider trade | 4 | 2026-02-03 | 2026-02-01 |
| Insider sale notice | 144 | 2026-01-30 | - |
| Insider sale notice | 144 | 2026-01-21 | - |
| Major company event (amended) | 8-K/A | 2026-01-07 | 2025-12-05 |
| Insider sale notice | 144 | 2026-01-02 | - |
| Major company event | 8-K | 2025-12-11 | 2025-12-05 |